glp-1 hypothalamus Glucagon, and Thermogenesis Insights into a possible role
Description
Want to hear more from an expert
While generally considered safe for most individuals, the evidence supporting their use specifically for GLP-1-related digestive symptoms remains limited and largely anecdotal
A planned transition between medications is always preferable to an abrupt stop
A growing body of evidence shows associations of genetic variants of TPH1/2, SERT, and 5-HTRs with metabolic diseases such as obesity, T2D, and MAFLD [186192]
Therapies that offer better efficacy could be saved for sicker diabetic patients
How much weight can they expect to lose
